Literature DB >> 6260823

Hexose transport in normal and SV40-transformed human endothelial cells in culture.

R F Corkey, B E Corkey, M A Gimbrone.   

Abstract

The mechanism of glucose entry into human vascular endothelial cells was studied in monolayer cultures of normal (primary) and virally (SV40) transformed umbilical vein endothelium. Radioisotopic uptake studies with the glucose analogues 2-deoxy-D-glucose, and 3-O-methyl-D-glucose, and the nonmetabolizable stereoisomer L-glucose, indicated the presence of a saturable, stereospecific hexose carrier mechanism in both cell types. In other experiments with D-glucose and 3-O-methyl-D-glucose, the phenomenon of countertransport was demonstrable. Hexose transport was not affected by KCN, dinitrophenol, or ouabain, but was inhibited by phloretin and phlorizin in a pattern consistent with facilitated diffusion. Kinetic constants were obtained for both 2-deoxy-D-glucose and 3-O-methyl-D-glucose uptake. Similar Km values (range, 3.3-4.7 mM) were noted with normal and transformed cells, whereas the apparent Vmax was 0.56 nmol/microliter cytosol/minute for primary cells and 1.7-2.5 nmol/mu cytosol/minute for transformed cells. Under standard culture conditions, as well as following 18 hours of serum deprivation, insulin at concentrations up to 10(-5) M did not appear to influence hexose uptake in either cell type. Metabolism of 14C(U)-D-glucose to 14CO2 also was not stimulated by insulin. The presence of an insulin-insensitive, facilitated transport system for glucose in vascular endothelium has relevance for glucose metabolism in this tissue, and potentially for the association of certain vascular diseases (e.g., diabetic microangiopathy, atherosclerosis) with altered glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260823     DOI: 10.1002/jcp.1041060312

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Cloning and sequencing of a trophoblast-endothelial-activated lymphocyte surface protein: cDNA sequence and genomic structure.

Authors:  J R Voland; R J Wyzykowski; M Huang; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.

Authors:  C F Kwok; B J Goldstein; D Muller-Wieland; T S Lee; C R Kahn; G L King
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  High glucose induces DNA damage in cultured human endothelial cells.

Authors:  M Lorenzi; D F Montisano; S Toledo; A Barrieux
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  Expression of amino acid transport systems in cultured human umbilical vein endothelial cells.

Authors:  G E Mann; J D Pearson; C J Sheriff; V J Toothill
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

5.  Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis.

Authors:  Jørn Ditzel; Hans-Henrik Lervang
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

6.  Endothelial cell uptake of adenosine in canine skeletal muscle.

Authors:  M W Gorman; J B Bassingthwaighte; R A Olsson; H V Sparks
Journal:  Am J Physiol       Date:  1986-03

7.  Deoxyglucose uptake by mouse astrocytes: effects of temperature and retrovirus infection.

Authors:  J M Vann; A J Goldman; P F Szurek; B R Brooks
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

8.  The effects of 7-hour local hyperglycaemia on forearm macro and microcirculatory blood flow and vascular reactivity in healthy man.

Authors:  A J Houben; N C Schaper; C H de Haan; F C Huvers; D W Slaaf; P W de Leeuw; A C Nieuwenhuijzen Kruseman
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

9.  Hormonal control of inflammatory responses.

Authors:  J Garcia-Leme; S P Farsky
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.